HaploidenticalHSCT for hemoglobinopathies: improved outcomes with TCR alpha beta(+)/CD19(+)-depleted grafts

Gaziev, J; Isgro, A; Sodani, P; Paciaroni, K; De Angelis, G; Marziali, M; Ribersani, M; Alfieri, C; Lanti, A; Galluccio, T; Adorno, G; Andreani, M

Gaziev, J (reprint author), Policlin Tor Vergata, Mediterranean Inst Hematol, Int Ctr Transplantat Thalassemia & Sickle Cell An, Viale Oxford 81, I-00133 Rome, Italy.

BLOOD ADVANCES, 2018; 2 (3): 263

Abstract

We examined outcomes of haploidentical hematopoietic cell transplantation (haplo-HCT) using T-cell receptor alpha beta(+) (TCR alpha beta(+))/CD19(+)-......

Full Text Link